Patel M B, Stewart J M, Loud A V, Anversa P, Wang J, Fiegel L, Hintze T H
Department of Physiology, New York Medical College, Valhalla 10595.
Circulation. 1991 Nov;84(5):2091-100. doi: 10.1161/01.cir.84.5.2091.
We have previously shown that chronic elevation of plasma norepinephrine leads to a functional independent increase in left ventricular weight. The goals of the present study were to determine quantitatively the component of the myocardium that accounted for the observed structural changes and to determine the function of the hypertrophied myocardium.
Mongrel dogs were chronically instrumented for measurement of arterial and left ventricular pressures, left ventricular internal diameter, and left ventricular wall thickness. Subcutaneous osmotic pumps were implanted to release norepinephrine continuously for 28 days. Hemodynamics were measured with dogs in the quietly resting state and during infusions of isoproterenol at 0.1 and 0.5 micrograms/kg/min before and on days 14 and 28 during the infusion of norepinephrine. The hemodynamic response to 10 micrograms/kg phenylephrine, given as a bolus, was also assessed before norepinephrine and 28 days during the infusion of norepinephrine, and the end-systolic pressure-diameter or wall-stress-diameter relations were calculated. On day 28, hearts were arrested in diastole and perfusion fixed in situ. Tissue samples were prepared for electron microscopy and morphometry. Hemodynamic studies showed that isoproterenol (0.5 micrograms/kg/min) reduced mean arterial pressure (MAP) to the same point on each experimental day, and the increases in indexes of contractility were reduced during norepinephrine infusion. Left ventricular dP/dtmax increased 131 +/- 24% on control day, only 67 +/- 20% on day 14, and 55 +/- 18% on day 28. Similar changes were observed in dP/dt/DP40 and dP/dt/end-diastolic circumference. However, Emax, the slope of the end-systolic pressure-diameter or wall stress diameter relations, was unchanged, suggesting that inotropic state was not altered. Morphometric studies showed that the cross-sectional area of myocytes increased by 55%, but myocyte and capillary densities decreased by 34% and 29%, respectively (p less than 0.05) in dogs with high norepinephrine levels. There were no differences in volume fractions of myocytes, capillary lumen, or interstitium or capillary-to-myocyte ratio.
The myocardium of dogs with high norepinephrine levels shows reduced inotropic response to beta-adrenergic stimulation despite the increases in left ventricular mass and left ventricular wall thickness, which are a result of growth of the cardiac myocytes and characteristic of concentric hypertrophy. These data suggest that chronic adrenergic stimulation of the heart reduces the beta-receptor coupling to the contractile response without importantly compromising left ventricular function.
我们之前已经表明,血浆去甲肾上腺素的长期升高会导致左心室重量功能性独立增加。本研究的目的是定量确定导致观察到的结构变化的心肌成分,并确定肥厚心肌的功能。
对杂种狗进行长期仪器植入,以测量动脉压和左心室压力、左心室内径和左心室壁厚度。植入皮下渗透泵以持续释放去甲肾上腺素28天。在安静休息状态下以及在去甲肾上腺素输注前、输注第14天和第28天期间,以0.1和0.5微克/千克/分钟的速率输注异丙肾上腺素时,测量杂种狗的血流动力学。在去甲肾上腺素输注前和输注第28天期间,还评估了静脉推注10微克/千克苯肾上腺素后的血流动力学反应,并计算了收缩末期压力-直径或壁应力-直径关系。在第28天,使心脏在舒张期停搏并原位灌注固定。制备组织样本用于电子显微镜检查和形态测量。血流动力学研究表明,异丙肾上腺素(0.5微克/千克/分钟)在每个实验日将平均动脉压(MAP)降低到相同水平,并且在去甲肾上腺素输注期间收缩性指标的增加减少。左心室dP/dtmax在对照日增加131±24%,在第14天仅增加67±20%,在第28天增加55±18%。在dP/dt/DP40和dP/dt/舒张末期周长方面观察到类似变化。然而,Emax,即收缩末期压力-直径或壁应力-直径关系的斜率,未改变,表明心肌收缩力状态未改变。形态测量研究表明,去甲肾上腺素水平高的狗的心肌细胞横截面积增加了55%,但心肌细胞和毛细血管密度分别降低了34%和29%(p<0.05)。心肌细胞、毛细血管腔或间质的体积分数或毛细血管与心肌细胞的比率没有差异。
去甲肾上腺素水平高的狗的心肌对β-肾上腺素能刺激的心肌收缩反应降低,尽管左心室质量和左心室壁厚度增加,这是心肌细胞生长的结果,也是同心性肥大的特征。这些数据表明,心脏的慢性肾上腺素能刺激会降低β-受体与收缩反应的偶联,而不会严重损害左心室功能。